世界のグルコース依存性インスリン分泌性受容体市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Glucose Dependent Insulinotropic Receptor Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A14990 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、グルコース依存性インスリン分泌性受容体のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。グルコース依存性インスリン分泌性受容体の種類別市場規模（DA-1241、GSK-2041706、HD-0471042、HD-0471953、HOB-047、MBX-2982、その他）、用途別市場規模（2型糖尿病、肥満、慢性閉塞性肺疾患（COPD）、脂質異常症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・グルコース依存性インスリン分泌性受容体の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amgen Inc、Arena Pharmaceuticals Inc、CymaBay Therapeutics Inc、Dong-A Socio Holdings Co Ltd、F. Hoffmann-La Roche Ltd、GlaxoSmithKline Plc、Hyundai Pharmaceutical Co Ltd、Kowa Co Ltd、Merck & Co Inc、Novartis AG、Taisho Pharmaceutical Holdings Co Ltd、Takeda Pharmaceutical Co Ltd、Yuhan Corp ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：DA-1241、GSK-2041706、HD-0471042、HD-0471953、HOB-047、MBX-2982、その他 ・用途別分析2016年-2026年：2型糖尿病、肥満、慢性閉塞性肺疾患（COPD）、脂質異常症、その他 ・グルコース依存性インスリン分泌性受容体の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・グルコース依存性インスリン分泌性受容体のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・グルコース依存性インスリン分泌性受容体のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・グルコース依存性インスリン分泌性受容体の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・グルコース依存性インスリン分泌性受容体の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Glucose Dependent Insulinotropic Receptor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Glucose Dependent Insulinotropic Receptor size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Glucose Dependent Insulinotropic Receptor market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Glucose Dependent Insulinotropic Receptor market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
DA-1241
GSK-2041706
HD-0471042
HD-0471953
HOB-047
MBX-2982
Others

Market segment by Application, can be divided into
Type 2 Diabetes
Obesity
Chronic Obstructive Pulmonary Disease (COPD)
Dyslipidemia
Others

Market segment by players, this report covers
Amgen Inc
Arena Pharmaceuticals Inc
CymaBay Therapeutics Inc
Dong-A Socio Holdings Co Ltd
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc
Hyundai Pharmaceutical Co Ltd
Kowa Co Ltd
Merck & Co Inc
Novartis AG
Taisho Pharmaceutical Holdings Co Ltd
Takeda Pharmaceutical Co Ltd
Yuhan Corp

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Glucose Dependent Insulinotropic Receptor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Glucose Dependent Insulinotropic Receptor, with revenue, gross margin and global market share of Glucose Dependent Insulinotropic Receptor from 2019 to 2021.
Chapter 3, the Glucose Dependent Insulinotropic Receptor competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Glucose Dependent Insulinotropic Receptor market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Glucose Dependent Insulinotropic Receptor research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Glucose Dependent Insulinotropic Receptor
1.2 Classification of Glucose Dependent Insulinotropic Receptor by Type
1.2.1 Overview: Global Glucose Dependent Insulinotropic Receptor Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Type in 2020
1.2.3 DA-1241
1.2.4 GSK-2041706
1.2.5 HD-0471042
1.2.6 HD-0471953
1.2.7 HOB-047
1.2.8 MBX-2982
1.2.9 Others
1.3 Global Glucose Dependent Insulinotropic Receptor Market by Application
1.3.1 Overview: Global Glucose Dependent Insulinotropic Receptor Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Type 2 Diabetes
1.3.3 Obesity
1.3.4 Chronic Obstructive Pulmonary Disease (COPD)
1.3.5 Dyslipidemia
1.3.6 Others
1.4 Global Glucose Dependent Insulinotropic Receptor Market Size & Forecast
1.5 Global Glucose Dependent Insulinotropic Receptor Market Size and Forecast by Region
1.5.1 Global Glucose Dependent Insulinotropic Receptor Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Glucose Dependent Insulinotropic Receptor Market Size by Region, (2016-2021)
1.5.3 North America Glucose Dependent Insulinotropic Receptor Market Size and Prospect (2016-2026)
1.5.4 Europe Glucose Dependent Insulinotropic Receptor Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size and Prospect (2016-2026)
1.5.6 South America Glucose Dependent Insulinotropic Receptor Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Glucose Dependent Insulinotropic Receptor Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Glucose Dependent Insulinotropic Receptor Market Drivers
1.6.2 Glucose Dependent Insulinotropic Receptor Market Restraints
1.6.3 Glucose Dependent Insulinotropic Receptor Trends Analysis
2 Company Profiles
2.1 Amgen Inc
2.1.1 Amgen Inc Details
2.1.2 Amgen Inc Major Business
2.1.3 Amgen Inc Glucose Dependent Insulinotropic Receptor Product and Solutions
2.1.4 Amgen Inc Glucose Dependent Insulinotropic Receptor Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Amgen Inc Recent Developments and Future Plans
2.2 Arena Pharmaceuticals Inc
2.2.1 Arena Pharmaceuticals Inc Details
2.2.2 Arena Pharmaceuticals Inc Major Business
2.2.3 Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Product and Solutions
2.2.4 Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Arena Pharmaceuticals Inc Recent Developments and Future Plans
2.3 CymaBay Therapeutics Inc
2.3.1 CymaBay Therapeutics Inc Details
2.3.2 CymaBay Therapeutics Inc Major Business
2.3.3 CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Product and Solutions
2.3.4 CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 CymaBay Therapeutics Inc Recent Developments and Future Plans
2.4 Dong-A Socio Holdings Co Ltd
2.4.1 Dong-A Socio Holdings Co Ltd Details
2.4.2 Dong-A Socio Holdings Co Ltd Major Business
2.4.3 Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product and Solutions
2.4.4 Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Dong-A Socio Holdings Co Ltd Recent Developments and Future Plans
2.5 F. Hoffmann-La Roche Ltd
2.5.1 F. Hoffmann-La Roche Ltd Details
2.5.2 F. Hoffmann-La Roche Ltd Major Business
2.5.3 F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Product and Solutions
2.5.4 F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.6 GlaxoSmithKline Plc
2.6.1 GlaxoSmithKline Plc Details
2.6.2 GlaxoSmithKline Plc Major Business
2.6.3 GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Product and Solutions
2.6.4 GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 GlaxoSmithKline Plc Recent Developments and Future Plans
2.7 Hyundai Pharmaceutical Co Ltd
2.7.1 Hyundai Pharmaceutical Co Ltd Details
2.7.2 Hyundai Pharmaceutical Co Ltd Major Business
2.7.3 Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product and Solutions
2.7.4 Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Hyundai Pharmaceutical Co Ltd Recent Developments and Future Plans
2.8 Kowa Co Ltd
2.8.1 Kowa Co Ltd Details
2.8.2 Kowa Co Ltd Major Business
2.8.3 Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Product and Solutions
2.8.4 Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Kowa Co Ltd Recent Developments and Future Plans
2.9 Merck & Co Inc
2.9.1 Merck & Co Inc Details
2.9.2 Merck & Co Inc Major Business
2.9.3 Merck & Co Inc Glucose Dependent Insulinotropic Receptor Product and Solutions
2.9.4 Merck & Co Inc Glucose Dependent Insulinotropic Receptor Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Merck & Co Inc Recent Developments and Future Plans
2.10 Novartis AG
2.10.1 Novartis AG Details
2.10.2 Novartis AG Major Business
2.10.3 Novartis AG Glucose Dependent Insulinotropic Receptor Product and Solutions
2.10.4 Novartis AG Glucose Dependent Insulinotropic Receptor Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Novartis AG Recent Developments and Future Plans
2.11 Taisho Pharmaceutical Holdings Co Ltd
2.11.1 Taisho Pharmaceutical Holdings Co Ltd Details
2.11.2 Taisho Pharmaceutical Holdings Co Ltd Major Business
2.11.3 Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product and Solutions
2.11.4 Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Taisho Pharmaceutical Holdings Co Ltd Recent Developments and Future Plans
2.12 Takeda Pharmaceutical Co Ltd
2.12.1 Takeda Pharmaceutical Co Ltd Details
2.12.2 Takeda Pharmaceutical Co Ltd Major Business
2.12.3 Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product and Solutions
2.12.4 Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Takeda Pharmaceutical Co Ltd Recent Developments and Future Plans
2.13 Yuhan Corp
2.13.1 Yuhan Corp Details
2.13.2 Yuhan Corp Major Business
2.13.3 Yuhan Corp Glucose Dependent Insulinotropic Receptor Product and Solutions
2.13.4 Yuhan Corp Glucose Dependent Insulinotropic Receptor Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Yuhan Corp Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Glucose Dependent Insulinotropic Receptor Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Glucose Dependent Insulinotropic Receptor Players Market Share
3.2.2 Top 10 Glucose Dependent Insulinotropic Receptor Players Market Share
3.2.3 Market Competition Trend
3.3 Glucose Dependent Insulinotropic Receptor Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Glucose Dependent Insulinotropic Receptor Revenue and Market Share by Type (2016-2021)
4.2 Global Glucose Dependent Insulinotropic Receptor Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Application (2016-2021)
5.2 Glucose Dependent Insulinotropic Receptor Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Glucose Dependent Insulinotropic Receptor Revenue by Type (2016-2026)
6.2 North America Glucose Dependent Insulinotropic Receptor Revenue by Application (2016-2026)
6.3 North America Glucose Dependent Insulinotropic Receptor Market Size by Country
6.3.1 North America Glucose Dependent Insulinotropic Receptor Revenue by Country (2016-2026)
6.3.2 United States Glucose Dependent Insulinotropic Receptor Market Size and Forecast (2016-2026)
6.3.3 Canada Glucose Dependent Insulinotropic Receptor Market Size and Forecast (2016-2026)
6.3.4 Mexico Glucose Dependent Insulinotropic Receptor Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Glucose Dependent Insulinotropic Receptor Revenue by Type (2016-2026)
7.2 Europe Glucose Dependent Insulinotropic Receptor Revenue by Application (2016-2026)
7.3 Europe Glucose Dependent Insulinotropic Receptor Market Size by Country
7.3.1 Europe Glucose Dependent Insulinotropic Receptor Revenue by Country (2016-2026)
7.3.2 Germany Glucose Dependent Insulinotropic Receptor Market Size and Forecast (2016-2026)
7.3.3 France Glucose Dependent Insulinotropic Receptor Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Glucose Dependent Insulinotropic Receptor Market Size and Forecast (2016-2026)
7.3.5 Russia Glucose Dependent Insulinotropic Receptor Market Size and Forecast (2016-2026)
7.3.6 Italy Glucose Dependent Insulinotropic Receptor Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Glucose Dependent Insulinotropic Receptor Revenue by Type (2016-2026)
8.2 Asia-Pacific Glucose Dependent Insulinotropic Receptor Revenue by Application (2016-2026)
8.3 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Region
8.3.1 Asia-Pacific Glucose Dependent Insulinotropic Receptor Revenue by Region (2016-2026)
8.3.2 China Glucose Dependent Insulinotropic Receptor Market Size and Forecast (2016-2026)
8.3.3 Japan Glucose Dependent Insulinotropic Receptor Market Size and Forecast (2016-2026)
8.3.4 South Korea Glucose Dependent Insulinotropic Receptor Market Size and Forecast (2016-2026)
8.3.5 India Glucose Dependent Insulinotropic Receptor Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Glucose Dependent Insulinotropic Receptor Market Size and Forecast (2016-2026)
8.3.7 Australia Glucose Dependent Insulinotropic Receptor Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Glucose Dependent Insulinotropic Receptor Revenue by Type (2016-2026)
9.2 South America Glucose Dependent Insulinotropic Receptor Revenue by Application (2016-2026)
9.3 South America Glucose Dependent Insulinotropic Receptor Market Size by Country
9.3.1 South America Glucose Dependent Insulinotropic Receptor Revenue by Country (2016-2026)
9.3.2 Brazil Glucose Dependent Insulinotropic Receptor Market Size and Forecast (2016-2026)
9.3.3 Argentina Glucose Dependent Insulinotropic Receptor Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Glucose Dependent Insulinotropic Receptor Revenue by Type (2016-2026)
10.2 Middle East & Africa Glucose Dependent Insulinotropic Receptor Revenue by Application (2016-2026)
10.3 Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Country
10.3.1 Middle East & Africa Glucose Dependent Insulinotropic Receptor Revenue by Country (2016-2026)
10.3.2 Turkey Glucose Dependent Insulinotropic Receptor Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Glucose Dependent Insulinotropic Receptor Market Size and Forecast (2016-2026)
10.3.4 UAE Glucose Dependent Insulinotropic Receptor Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Glucose Dependent Insulinotropic Receptor Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Glucose Dependent Insulinotropic Receptor Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Glucose Dependent Insulinotropic Receptor Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Glucose Dependent Insulinotropic Receptor Revenue (USD Million) by Region (2016-2021)
Table 5. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Region (2021-2026)
Table 6. Amgen Inc Corporate Information, Head Office, and Major Competitors
Table 7. Amgen Inc Major Business
Table 8. Amgen Inc Glucose Dependent Insulinotropic Receptor Product and Solutions
Table 9. Amgen Inc Glucose Dependent Insulinotropic Receptor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Arena Pharmaceuticals Inc Corporate Information, Head Office, and Major Competitors
Table 11. Arena Pharmaceuticals Inc Major Business
Table 12. Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Product and Solutions
Table 13. Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. CymaBay Therapeutics Inc Corporate Information, Head Office, and Major Competitors
Table 15. CymaBay Therapeutics Inc Major Business
Table 16. CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Product and Solutions
Table 17. CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Dong-A Socio Holdings Co Ltd Corporate Information, Head Office, and Major Competitors
Table 19. Dong-A Socio Holdings Co Ltd Major Business
Table 20. Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product and Solutions
Table 21. Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. F. Hoffmann-La Roche Ltd Corporate Information, Head Office, and Major Competitors
Table 23. F. Hoffmann-La Roche Ltd Major Business
Table 24. F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Product and Solutions
Table 25. F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. GlaxoSmithKline Plc Corporate Information, Head Office, and Major Competitors
Table 27. GlaxoSmithKline Plc Major Business
Table 28. GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Product and Solutions
Table 29. GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Hyundai Pharmaceutical Co Ltd Corporate Information, Head Office, and Major Competitors
Table 31. Hyundai Pharmaceutical Co Ltd Major Business
Table 32. Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product and Solutions
Table 33. Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Kowa Co Ltd Corporate Information, Head Office, and Major Competitors
Table 35. Kowa Co Ltd Major Business
Table 36. Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Product and Solutions
Table 37. Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Merck & Co Inc Corporate Information, Head Office, and Major Competitors
Table 39. Merck & Co Inc Major Business
Table 40. Merck & Co Inc Glucose Dependent Insulinotropic Receptor Product and Solutions
Table 41. Merck & Co Inc Glucose Dependent Insulinotropic Receptor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 43. Novartis AG Major Business
Table 44. Novartis AG Glucose Dependent Insulinotropic Receptor Product and Solutions
Table 45. Novartis AG Glucose Dependent Insulinotropic Receptor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Taisho Pharmaceutical Holdings Co Ltd Corporate Information, Head Office, and Major Competitors
Table 47. Taisho Pharmaceutical Holdings Co Ltd Major Business
Table 48. Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product and Solutions
Table 49. Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Takeda Pharmaceutical Co Ltd Corporate Information, Head Office, and Major Competitors
Table 51. Takeda Pharmaceutical Co Ltd Major Business
Table 52. Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product and Solutions
Table 53. Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Yuhan Corp Corporate Information, Head Office, and Major Competitors
Table 55. Yuhan Corp Major Business
Table 56. Yuhan Corp Glucose Dependent Insulinotropic Receptor Product and Solutions
Table 57. Yuhan Corp Glucose Dependent Insulinotropic Receptor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Glucose Dependent Insulinotropic Receptor Revenue (USD Million) by Players (2019-2021)
Table 59. Global Glucose Dependent Insulinotropic Receptor Revenue Share by Players (2019-2021)
Table 60. Breakdown of Glucose Dependent Insulinotropic Receptor by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Glucose Dependent Insulinotropic Receptor Players Head Office, Products and Services Provided
Table 62. Glucose Dependent Insulinotropic Receptor Mergers & Acquisitions in the Past Five Years
Table 63. Glucose Dependent Insulinotropic Receptor New Entrants and Expansion Plans
Table 64. Global Glucose Dependent Insulinotropic Receptor Revenue (USD Million) by Type (2016-2021)
Table 65. Global Glucose Dependent Insulinotropic Receptor Revenue Share by Type (2016-2021)
Table 66. Global Glucose Dependent Insulinotropic Receptor Revenue Forecast by Type (2021-2026)
Table 67. Global Glucose Dependent Insulinotropic Receptor Revenue by Application (2016-2021)
Table 68. Global Glucose Dependent Insulinotropic Receptor Revenue Forecast by Application (2021-2026)
Table 69. North America Glucose Dependent Insulinotropic Receptor Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Glucose Dependent Insulinotropic Receptor Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Glucose Dependent Insulinotropic Receptor Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Glucose Dependent Insulinotropic Receptor Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Glucose Dependent Insulinotropic Receptor Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Glucose Dependent Insulinotropic Receptor Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Glucose Dependent Insulinotropic Receptor Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Glucose Dependent Insulinotropic Receptor Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Glucose Dependent Insulinotropic Receptor Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Glucose Dependent Insulinotropic Receptor Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Glucose Dependent Insulinotropic Receptor Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Glucose Dependent Insulinotropic Receptor Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Glucose Dependent Insulinotropic Receptor Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Glucose Dependent Insulinotropic Receptor Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Glucose Dependent Insulinotropic Receptor Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Glucose Dependent Insulinotropic Receptor Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Glucose Dependent Insulinotropic Receptor Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Glucose Dependent Insulinotropic Receptor Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Glucose Dependent Insulinotropic Receptor Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Glucose Dependent Insulinotropic Receptor Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Glucose Dependent Insulinotropic Receptor Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Glucose Dependent Insulinotropic Receptor Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Glucose Dependent Insulinotropic Receptor Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Glucose Dependent Insulinotropic Receptor Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Glucose Dependent Insulinotropic Receptor Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Glucose Dependent Insulinotropic Receptor Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Glucose Dependent Insulinotropic Receptor Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Glucose Dependent Insulinotropic Receptor Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Glucose Dependent Insulinotropic Receptor Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Glucose Dependent Insulinotropic Receptor Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Glucose Dependent Insulinotropic Receptor Picture
Figure 2. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Type in 2020
Figure 3. DA-1241
Figure 4. GSK-2041706
Figure 5. HD-0471042
Figure 6. HD-0471953
Figure 7. HOB-047
Figure 8. MBX-2982
Figure 9. Others
Figure 10. Glucose Dependent Insulinotropic Receptor Revenue Market Share by Application in 2020
Figure 11. Type 2 Diabetes Picture
Figure 12. Obesity Picture
Figure 13. Chronic Obstructive Pulmonary Disease (COPD) Picture
Figure 14. Dyslipidemia Picture
Figure 15. Others Picture
Figure 16. Global Glucose Dependent Insulinotropic Receptor Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 17. Global Glucose Dependent Insulinotropic Receptor Revenue and Forecast (2016-2026) & (USD Million)
Figure 18. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Region (2016-2026)
Figure 19. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Region in 2020
Figure 20. North America Glucose Dependent Insulinotropic Receptor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Europe Glucose Dependent Insulinotropic Receptor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Asia-Pacific Glucose Dependent Insulinotropic Receptor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. South America Glucose Dependent Insulinotropic Receptor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. Middle East and Africa Glucose Dependent Insulinotropic Receptor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 25. Glucose Dependent Insulinotropic Receptor Market Drivers
Figure 26. Glucose Dependent Insulinotropic Receptor Market Restraints
Figure 27. Glucose Dependent Insulinotropic Receptor Market Trends
Figure 28. Amgen Inc Recent Developments and Future Plans
Figure 29. Arena Pharmaceuticals Inc Recent Developments and Future Plans
Figure 30. CymaBay Therapeutics Inc Recent Developments and Future Plans
Figure 31. Dong-A Socio Holdings Co Ltd Recent Developments and Future Plans
Figure 32. F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
Figure 33. GlaxoSmithKline Plc Recent Developments and Future Plans
Figure 34. Hyundai Pharmaceutical Co Ltd Recent Developments and Future Plans
Figure 35. Kowa Co Ltd Recent Developments and Future Plans
Figure 36. Merck & Co Inc Recent Developments and Future Plans
Figure 37. Novartis AG Recent Developments and Future Plans
Figure 38. Taisho Pharmaceutical Holdings Co Ltd Recent Developments and Future Plans
Figure 39. Takeda Pharmaceutical Co Ltd Recent Developments and Future Plans
Figure 40. Yuhan Corp Recent Developments and Future Plans
Figure 41. Global Glucose Dependent Insulinotropic Receptor Revenue Share by Players in 2020
Figure 42. Glucose Dependent Insulinotropic Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 43. Global Top 3 Players Glucose Dependent Insulinotropic Receptor Revenue Market Share in 2020
Figure 44. Global Top 10 Players Glucose Dependent Insulinotropic Receptor Revenue Market Share in 2020
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 46. Global Glucose Dependent Insulinotropic Receptor Revenue Share by Type in 2020
Figure 47. Global Glucose Dependent Insulinotropic Receptor Market Share Forecast by Type (2021-2026)
Figure 48. Global Glucose Dependent Insulinotropic Receptor Revenue Share by Application in 2020
Figure 49. Global Glucose Dependent Insulinotropic Receptor Market Share Forecast by Application (2021-2026)
Figure 50. North America Glucose Dependent Insulinotropic Receptor Sales Market Share by Type (2016-2026)
Figure 51. North America Glucose Dependent Insulinotropic Receptor Sales Market Share by Application (2016-2026)
Figure 52. North America Glucose Dependent Insulinotropic Receptor Revenue Market Share by Country (2016-2026)
Figure 53. United States Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Canada Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Mexico Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Europe Glucose Dependent Insulinotropic Receptor Sales Market Share by Type (2016-2026)
Figure 57. Europe Glucose Dependent Insulinotropic Receptor Sales Market Share by Application (2016-2026)
Figure 58. Europe Glucose Dependent Insulinotropic Receptor Revenue Market Share by Country (2016-2026)
Figure 59. Germany Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. France Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. United Kingdom Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Russia Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Italy Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Asia-Pacific Glucose Dependent Insulinotropic Receptor Sales Market Share by Type (2016-2026)
Figure 65. Asia-Pacific Glucose Dependent Insulinotropic Receptor Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Glucose Dependent Insulinotropic Receptor Revenue Market Share by Region (2016-2026)
Figure 67. China Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Japan Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South Korea Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. India Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Southeast Asia Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Australia Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. South America Glucose Dependent Insulinotropic Receptor Sales Market Share by Type (2016-2026)
Figure 74. South America Glucose Dependent Insulinotropic Receptor Sales Market Share by Application (2016-2026)
Figure 75. South America Glucose Dependent Insulinotropic Receptor Revenue Market Share by Country (2016-2026)
Figure 76. Brazil Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Argentina Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by Type (2016-2026)
Figure 79. Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by Application (2016-2026)
Figure 80. Middle East and Africa Glucose Dependent Insulinotropic Receptor Revenue Market Share by Country (2016-2026)
Figure 81. Turkey Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Saudi Arabia Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. UAE Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source

---